Rezultati pretraživanja
  1. 11. stu 2019.

    Learn more about against and respiratory in the presentation of Dr. Rainer Lichtenberger, our CEO, today at 5.45 PM during the “Infectious Disease Company Presentations” section Level 1/Hall B1/Room 7

  2. 22. lis 2019.

    We urgently need better . is developing a unique portfolio of broadly active and efficacious drugs based on . Our therapies are designed to treat and other severe respiratory viral infections with a unique approach.

  3. 17. sij 2019.
  4. 16. svi 2019.

    Scientists have discovered that a group of () activate the pathway in cells.

  5. Targeting a type of protein phosphatase prevents resistance to in mouse models of lung cancer

  6. 22. srp 2015.

    AstraZeneca suffers setback as drug fails in eye

  7. 31. srp 2019.

    : Novel and unexpected link between and TNFa signaling in cells shown by Xie et al. provides rationale for combining with MEK inhibitors to treat lung cancer.

  8. 16. svi 2019.
  9. 22. kol 2019.

    Our report on market shows the growth prospects, newest trends, and possible challenges for and Learn more from the free sample report@

  10. 12. kol 2019.

    The MEKINIST segment will be growth frontier for market during 2023 due to increasing R&D on new patient pools. Learn more from the free sample report@

  11. 8. srp 2019.

    Genetically engineered zebrafish have saved the life of a young boy with a mystery illness. Read more:

  12. 2. stu 2016.
  13. 1. stu 2011.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.